Alkaline phosphatase and bone calcium parameters.

Area of Science:

• Biochemistry
• Bone Metabolism
• Toxicology

Background:

• Alkaline phosphatase is crucial for bone mineralization and metabolism.
• Cadmium is a known alkaline phosphatase inhibitor with potential effects on bone health.

Purpose of the Study:

• To investigate the in vivo effects of cadmium, an alkaline phosphatase inhibitor, on rat bone calcium content.
• To elucidate the relationship between alkaline phosphatase activity and bone calcification processes.

Main Methods:

• Radioisotopic method used to assess calcium content and exchange in rat bone.
• Measurement of serum alkaline phosphatase activity.
• Statistical analysis of correlations between enzyme activity and calcium parameters.

Main Results:

• Cadmium significantly decreased superficial and slow calcium exchanges (delta, Ve) and affected the crystallized calcium bone compartment (E).
• Reduced serum alkaline phosphatase activity correlated with decreased superficial calcium influx (Vo+) and crystallized bone calcium.
• Observed changes suggest cadmium-induced alterations in bone metabolism and calcification.

Conclusions:

• Alkaline phosphatase activity is closely linked to superficial calcium exchange and overall bone calcium content.
• Cadmium's inhibition of alkaline phosphatase disrupts bone metabolism, impacting calcification.
• Alkaline phosphatase may play a key role in regulating calcium content in deep bone phases via surface actions.